BNA
VRTX icon

BankChampaign National Association’s Vertex Pharmaceuticals VRTX Stock Holding History

BankChampaign National Association’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,374
Closed -$614K – 222
2026
Q1 		$614K Sell
1,374
-35
-2% -$16.3K 0.61% 66
2025
Q4 		$639K Buy
+1,409
New +$607K 0.63% 52

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

BankChampaign National Association's VRTX Position: Q2 2026 in Review

BankChampaign National Association sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 1,374 shares — an estimated $614K sold.

BankChampaign National Association first reported a position in VRTX in Q4 2025 and held it in 2 quarters. The position peaked at $639K in Q4 2025. 506 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • BankChampaign National Association reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • BankChampaign National Association sold 1,374 Vertex Pharmaceuticals shares in Q2 2026, an estimated $614K.
  • BankChampaign National Association first reported a position in Vertex Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • BankChampaign National Association's Vertex Pharmaceuticals position peaked at $639K in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on BankChampaign National Association's 13F filing for Q2 2026, filed 23 Jul 2026.